Biome Australia Limited (BIO) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

the founder and managing director of Biome Australia and our brands, Activated Probiotics and Activated Therapeutics. Thank you all for joining this morning to hear about our Q1 FY26 results. There was overwhelming requests for another webinar. We had a very successful webinar that was very well attended. only a couple of months ago. And after a stellar quarter, we thought it would be a perfect time to jump back on, give everyone a bit of an update on the most incredible record-breaking quarter that has just passed, and give everyone an opportunity to ask some questions. So with that in mind, with the 30 to 40 minutes we have scheduled, I'll only use 15 to 20 minutes for the background on the company and the presentation of Q1. then be very pleased to jump in with some questions. Happy to answer anything. If I can't answer it, I'll pass it along to the team, but I'm sure we can probably get through most things. With that in mind, please send any questions through the chat below in the Zoom screen. If you're unable to do so, feel free to send through any questions to support at activated.co and we'll do our best to get to everything. I think last webinar, we had about 35, 40 questions we got through. So we'll do our best to get to them all. And with that in mind, let's jump in. So very quick background on who Biome Australia is. So Biome Australia is an innovator in the healthcare space. We focus on clinically proven preventative medicines and microbiome-based therapeutics. Our products are primarily probiotics or targeted live bacteria products. In doing so, what we've done is really developed a new type of medicine looking at unique strains of bacteria, identifying their mechanism of action, how those strains work, and then applying them through human clinical trial...